The BREAST-AB Trial is a multi-center, randomized, double blind, placebo-controlled trial investigating the efficacy of local application of gentamicin, vancomycin and cefazolin in decreasing all-cause implant explantation after breast reconstruction.
Age ≥ 18 years
Biologically female
Signed informed consent
Immediate or delayed reconstructions
Pregnancy
Breast feeding
Known allergy towards Vancomycin, Gentamicin and Cefazolin
Known anaphylactic reaction towards other beta-lactam antibiotics or aminoglycosides
Mikkel Herly
Lead sponsor
Rigshospitalet, Denmark
Sponsor institution
University of Copenhagen
Collaborator
Herlev and Gentofte Hospital
Collaborator
Zealand University Hospital
Collaborator
Odense University Hospital
Collaborator
Vejle Hospital
Collaborator
Esbjerg Hospital - University Hospital of Southern Denmark
Collaborator
Aarhus University Hospital
Collaborator
Aalborg University Hospital
Collaborator